Davidson Kempner Capital Management’s Starling Oncology Warrant STLNW Stock Holding History
Bought
Maintained
Sold
Other funds holding STLNW
OMC
LP
DM
WAM
AGM
TCM
Davidson Kempner Capital Management's STLNW Position: Q2 2026 in Review
Davidson Kempner Capital Management held its Starling Oncology Warrant (STLNW) position steady in Q2 2026 at 318,710 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #222.
Davidson Kempner Capital Management first reported a position in STLNW in Q1 2021 and has held it in 22 quarters since. The position peaked at $551K in Q2 2021. 12 funds tracked by Wall St. Rank hold STLNW as of Q2 2026.
- Davidson Kempner Capital Management held 318,710 shares of Starling Oncology Warrant worth $13K as of Q2 2026.
- Davidson Kempner Capital Management left its Starling Oncology Warrant share count unchanged in Q2 2026.
- Starling Oncology Warrant made up ﹤0.01% of Davidson Kempner Capital Management's portfolio in Q2 2026, its #222 holding.
- Davidson Kempner Capital Management first reported a position in Starling Oncology Warrant in Q1 2021 and has held it in 22 quarters since.
- Davidson Kempner Capital Management's Starling Oncology Warrant position peaked at $551K in Q2 2021.
- 12 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q2 2026.
Based on Davidson Kempner Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.